|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
REVIEW
1Department of Internal Medicine, 4Department of Anatomy and Cell Biology, 6Department of Pathology, and 5Department of Pediatrics, Roy J. Carver College of Medicine; 3Department of Periodontics and Dows Institute for Dental Research, College of Dentistry; and 8Howard Hughes Medical Institute, University of Iowa, Iowa City, Iowa; 2Division of Pulmonary and Critical Care Medicine, University of Miami at Mount Sinai Medical Center, Miami Beach, Florida; and 7Division of Animal Science, University of Missouri-Columbia, Columbia, Missouri
ABSTRACT
Airway disease currently causes most of the morbidity and mortality in patients with cystic fibrosis (CF). However, understanding the pathogenesis of CF lung disease and developing novel therapeutic strategies have been hampered by the limitations of current models. Although the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) has been targeted in mice, CF mice fail to develop lung or pancreatic disease like that in humans. In many respects, the anatomy, biochemistry, physiology, size, and genetics of pigs resemble those of humans. Thus pigs with a targeted CFTR gene might provide a good model for CF. Here, we review aspects of porcine airways and lung that are relevant to CF.
This article has been cited by other articles:
![]() |
C. S. Rogers, D. A. Stoltz, D. K. Meyerholz, L. S. Ostedgaard, T. Rokhlina, P. J. Taft, M. P. Rogan, A. A. Pezzulo, P. H. Karp, O. A. Itani, et al. Disruption of the CFTR Gene Produces a Model of Cystic Fibrosis in Newborn Pigs Science, September 26, 2008; 321(5897): 1837 - 1841. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Verkman From the farm to the lab: the pig as a new model of cystic fibrosis lung disease Am J Physiol Lung Cell Mol Physiol, August 1, 2008; 295(2): L238 - L239. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |